drugset / Trial / NCT00027404

Study of Fluoxetine in Adults With Autistic Disorder

NCT00027404

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study to determine the effect of fluoxetine in the treatment of adult autism and on functional ability and behavior associated with autism. Evidence suggests abnormal serotonin function in autism. Fluoxetine is a selective inhibitor of the serotonin transporter.

Timeline

Start
2001-09
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule

Indications